Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹23 Cr
P/E Ratio
27.26
P/B Ratio
2.24
Industry P/E
37.25
Debt to Equity
0
ROE
7.84 %
ROCE
10.74 %
Div. Yield
0 %
Book Value
35.12
EPS
2.88
CFO
₹5.07 Cr
EBITDA
₹6.26 Cr
Net Profit
₹4.65 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Ishita Drugs
| -15.07 | 0.64 | -5.24 | 9.65 | 14.72 | 44.89 | 15.84 |
|
BSE Healthcare
| -7.27 | -1.01 | -0.76 | 19.87 | 19.29 | 22.12 | 9.77 |
|
BSE Small Cap
| -12.38 | 0.32 | -4.19 | 2.45 | 17.96 | 35.18 | 15.87 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Ishita Drugs
| 21.06 | 39.01 | 11.89 | 47.10 | 163.45 | -25.67 | -33.01 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 | 32.11 | -6.85 | -23.41 |
|
BSE Healthcare
| 43.09 | 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 425.60 | 6,920.24 | 25.22 | 12.5 | |
| 5,063.50 | 8,422.94 | 35.6 | 43.77 | |
| 680.85 | 6,674.72 | 75.6 | 4.01 | |
| 653.45 | 6,028.82 | 22.37 | 12.68 |
No Review & Analysis are available.
Ishita Drugs & Industries Limited manufactures and sells active pharma ingredients and drug intermediates in India. It offers active pharma ingredients, such as sulfa drugs/sulfonamides, vitamins, fluoro quinolones, antibiotics, anthelmintics,... iodides and citrates, food additives/excipients, and others; fine chemicals; and drug intermediaries, as well as finished dosage forms. The company also provides contract manufacturing services for various drug intermediates, fine chemicals, or specialty chemicals. It serves regulatory authorities and pharmaceutical companies. The company exports its products to approximately 25 countries. Ishita Drugs & Industries Limited was incorporated in 1992 and is based in Ahmedabad, India. Read more
Incorporated
1992
Chairman
--
Managing Director
Jagdish Agrawal
Headquarters
Ahmedabad Dist, Gujarat
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The total asset value of Ishita Drugs & Industries Ltd stood at ₹ 15 Cr as on 31-Dec-24
The share price of Ishita Drugs & Industries Ltd is ₹78.50 (BSE) as of 25-Apr-2025 IST. Ishita Drugs & Industries Ltd has given a return of 14.72% in the last 3 years.
Ishita Drugs & Industries Ltd has a market capitalisation of ₹ 23 Cr as on 25-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Ishita Drugs & Industries Ltd is 2.24 times as on 25-Apr-2025, a 57% discount to its peers’ median range of 5.15 times.
The P/E ratio of Ishita Drugs & Industries Ltd is 27.26 times as on 25-Apr-2025, a 27% discount to its peers’ median range of 37.25 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Ishita Drugs & Industries Ltd and enter the required number of quantities and click on buy to purchase the shares of Ishita Drugs & Industries Ltd.
Ishita Drugs & Industries Limited manufactures and sells active pharma ingredients and drug intermediates in India. It offers active pharma ingredients, such as sulfa drugs/sulfonamides, vitamins, fluoro quinolones, antibiotics, anthelmintics, iodides and citrates, food additives/excipients, and others; fine chemicals; and drug intermediaries, as well as finished dosage forms. The company also provides contract manufacturing services for various drug intermediates, fine chemicals, or specialty chemicals. It serves regulatory authorities and pharmaceutical companies. The company exports its products to approximately 25 countries. Ishita Drugs & Industries Limited was incorporated in 1992 and is based in Ahmedabad, India.
The prominent promoters of Ishita Drugs & Industries Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
UMANG FINANCIAL SERVICES LIMITED |
9.94%
|
|
SUMIT AGRAWAL |
9.77%
|
|
ABHA AGRAWAL |
8.39%
|
|
KRISHN SUMIT AGRAWAL |
4.68%
|
|
ISHITA OVERSEAS PRIVATE LIMITED |
4.35%
|
The chairman of the company is , and the managing director is Jagdish Agrawal.
There is no promoter pledging in Ishita Drugs & Industries Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
8,423
|
|
|
6,920
|
|
|
6,675
|
|
|
6,029
|
| Ishita Drugs & Industries Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
8.53
|
|
Operating margin(%)
|
6.08
|
|
Net Margin(%)
|
5.66
|
|
Dividend yield(%)
|
0
|
Yes, TTM profit after tax of Ishita Drugs & Industries Ltd was ₹1 Cr.
₹0.67
(
